Lipid accelerating the fibril of islet amyloid polypeptide aggravated the pancreatic islet injury in vitro and in vivo

[1]  S. Yagihashi,et al.  Pancreas Atrophy and Islet Amyloid Deposition in Patients With Elderly‐Onset Type 2 Diabetes , 2017, The Journal of clinical endocrinology and metabolism.

[2]  C. Soto,et al.  Prion-Like Protein Aggregates and Type 2 Diabetes. , 2017, Cold Spring Harbor perspectives in medicine.

[3]  P. Walther,et al.  Amyloid plaque structure and cell surface interactions of β-amyloid fibrils revealed by electron tomography , 2017, Scientific Reports.

[4]  D. Raleigh,et al.  Islet Amyloid Polypeptide Membrane Interactions: Effects of Membrane Composition. , 2017, Biochemistry.

[5]  A. Blom,et al.  C4b-binding Protein Protects β-Cells from Islet Amyloid Polypeptide-induced Cytotoxicity* , 2016, The Journal of Biological Chemistry.

[6]  C. Satriano,et al.  The Role of Cholesterol in Driving IAPP-Membrane Interactions. , 2016, Biophysical journal.

[7]  J. McConathy,et al.  Multimodality Review of Amyloid-related Diseases of the Central Nervous System. , 2016, Radiographics : a review publication of the Radiological Society of North America, Inc.

[8]  He Dong,et al.  Distinct Membrane Disruption Pathways Are Induced by 40-Residue β-Amyloid Peptides* , 2016, The Journal of Biological Chemistry.

[9]  Jianjun Pan,et al.  Polyglutamine aggregates impair lipid membrane integrity and enhance lipid membrane rigidity. , 2016, Biochimica et biophysica acta.

[10]  Shanhua Xu,et al.  Autocrine insulin increases plasma membrane K(ATP) channel via PI3K-VAMP2 pathway in MIN6 cells. , 2015, Biochemical and biophysical research communications.

[11]  S. An,et al.  Causative factors for formation of toxic islet amyloid polypeptide oligomer in type 2 diabetes mellitus , 2015, Clinical interventions in aging.

[12]  G. Westermark,et al.  Heparan Sulfate Proteoglycans Are Important for Islet Amyloid Formation and Islet Amyloid Polypeptide-induced Apoptosis* , 2015, The Journal of Biological Chemistry.

[13]  Wenjie Zheng,et al.  Inhibition of islet amyloid polypeptide fibril formation by selenium-containing phycocyanin and prevention of beta cell apoptosis. , 2014, Biomaterials.

[14]  D. Scott,et al.  The pathogenic mechanism of diabetes varies with the degree of overexpression and oligomerization of human amylin in the pancreatic islet β cells , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[15]  S. Kahn,et al.  Islet amyloid formation is an important determinant for inducing islet inflammation in high-fat-fed human IAPP transgenic mice , 2014, Diabetologia.

[16]  M. Bathe,et al.  Bayesian total internal reflection fluorescence correlation spectroscopy reveals hIAPP-induced plasma membrane domain organization in live cells. , 2014, Biophysical journal.

[17]  D. Raleigh,et al.  Islet amyloid polypeptide toxicity and membrane interactions , 2013, Proceedings of the National Academy of Sciences.

[18]  J. Brender,et al.  Cations as switches of amyloid-mediated membrane disruption mechanisms: calcium and IAPP. , 2013, Biophysical journal.

[19]  H. Jono,et al.  Interaction between amyloid fibril formation and extracellular matrix in the proceedings of VIIIth International Symposium on Familial Amyloidotic Polyneuropathy , 2012, Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis.

[20]  C. Rhodes,et al.  Translational control of glucose-induced islet amyloid polypeptide production in pancreatic islets. , 2012, Endocrinology.

[21]  H. Reber,et al.  Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway. , 2010, The American journal of pathology.

[22]  N. Opitz,et al.  Fluorescence microscopy studies on islet amyloid polypeptide fibrillation at heterogeneous and cellular membrane interfaces and its inhibition by resveratrol , 2009, FEBS letters.

[23]  J. Götz,et al.  Common features between diabetes mellitus and Alzheimer’s disease , 2009, Cellular and Molecular Life Sciences.

[24]  P. de Vos,et al.  Human Islet Amyloid Polypeptide Transgenic Mice: In Vivo and Ex Vivo Models for the Role of hIAPP in Type 2 Diabetes Mellitus , 2008, Experimental diabetes research.

[25]  Maarten F. M. Engel,et al.  Membrane damage by human islet amyloid polypeptide through fibril growth at the membrane , 2008, Proceedings of the National Academy of Sciences.

[26]  P. Butler,et al.  Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis. , 2008, Endocrine reviews.

[27]  K. Şahin,et al.  Effect of chromium on carbohydrate and lipid metabolism in a rat model of type 2 diabetes mellitus: the fat-fed, streptozotocin-treated rat. , 2007, Metabolism: clinical and experimental.

[28]  Johannes D. Veldhuis,et al.  Human Islet Amyloid Polypeptide Oligomers Disrupt Cell Coupling, Induce Apoptosis, and Impair Insulin Secretion in Isolated Human Islets , 2007, Diabetes.

[29]  J. Kistler,et al.  The aggregation potential of human amylin determines its cytotoxicity towards islet β‐cells , 2006, The FEBS journal.

[30]  I. Artner,et al.  Regulation of the insulin gene by glucose and fatty acids. , 2006, The Journal of nutrition.

[31]  P. Ramarao,et al.  Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening. , 2005, Pharmacological research.

[32]  Ian Parker,et al.  Calcium Dysregulation and Membrane Disruption as a Ubiquitous Neurotoxic Mechanism of Soluble Amyloid Oligomers*♦ , 2005, Journal of Biological Chemistry.

[33]  B. Kagan,et al.  Amyloidosis and Protein Folding , 2005, Science.

[34]  Josep Vidal,et al.  Increased dietary fat promotes islet amyloid formation and beta-cell secretory dysfunction in a transgenic mouse model of islet amyloid. , 2003, Diabetes.

[35]  G. Westermark,et al.  Effects of Free Fatty Acid on Polymerization of Islet Amyloid Polypeptide (IAPP) In Vitro and on Amyloid Fibril Formation in Cultivated Isolated Islets of Transgenic Mice Overexpressing Human IAPP , 2002, Molecular Medicine.

[36]  P. Lansbury,et al.  Protofibrillar islet amyloid polypeptide permeabilizes synthetic vesicles by a pore-like mechanism that may be relevant to type II diabetes. , 2002, Biochemistry.

[37]  D. Steiner,et al.  Islet Amyloid Development in a Mouse Strain Lacking Endogenous Islet Amyloid Polypeptide (IAPP) but Expressing Human IAPP , 2000, Molecular medicine.

[38]  G. Reaven,et al.  A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat. , 2000, Metabolism: clinical and experimental.

[39]  S. Kahn,et al.  The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. , 2000, Diabetes.

[40]  U Aebi,et al.  Amyloid fibril formation from full-length and fragments of amylin. , 2000, Journal of structural biology.

[41]  P. Lansbury,et al.  Amyloid fibrillogenesis: themes and variations. , 2000, Current opinion in structural biology.

[42]  R. Palmiter,et al.  Islet amyloid formation associated with hyperglycemia in transgenic mice with pancreatic beta cell expression of human islet amyloid polypeptide. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[43]  H. Makino,et al.  Islet amyloid polypeptide inhibits glucose-stimulated insulin secretion from isolated rat pancreatic islets. , 1989, Biochemical and biophysical research communications.

[44]  R. Holman,et al.  Islet amyloid, increased A-cells, reduced B-cells and exocrine fibrosis: quantitative changes in the pancreas in type 2 diabetes. , 1988, Diabetes research.

[45]  R. Turner,et al.  Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[46]  D. W. Hayden,et al.  Islet amyloid in type 2 human diabetes mellitus and adult diabetic cats contains a novel putative polypeptide hormone. , 1987, The American journal of pathology.

[47]  P. Morris,et al.  ISOLATION OF RAT PANCREATIC ISLETS BY DUCTAL INJECTION OF COLLAGENASE1 , 1986, Transplantation.

[48]  S. Störkel,et al.  Das Amyloid der Langerhansschen Inseln und seine Beziehung zum Diabetes mellitus* 1 , 1980 .

[49]  Bell Et.  Hyalinization of the islets of Langerhans in nondiabetic individuals. , 1959 .

[50]  D. Raleigh,et al.  In Vitro Studies of Membrane Permeability Induced by Amyloidogenic Polypeptides Using Large Unilamellar Vesicles. , 2016, Methods in molecular biology.

[51]  P. Butler,et al.  Islet amyloid polypeptide (IAPP) transgenic rodents as models for type 2 diabetes. , 2006, ILAR journal.

[52]  W. Saeger,et al.  Immunohistology of islet amyloid polypeptide in diabetes mellitus: Semi-qantitative studies in a post-mortem series , 2005, Virchows Archiv A.

[53]  L. Groop,et al.  The role of free fatty acid metabolism in the pathogenesis of insulin resistance in obesity and noninsulin-dependent diabetes mellitus. , 1991, The Journal of clinical endocrinology and metabolism.

[54]  H. Schneider,et al.  [Amyloid of islets of Langerhans and its relation to diabetes mellitus (author's transl)]. , 1980, Deutsche medizinische Wochenschrift.

[55]  P. Westermark,et al.  Quantitative studies on amyloid in the islets of Langerhans. , 1972, Upsala journal of medical sciences.

[56]  J. Ehrlich,et al.  Amyloidosis of the islets of Langerhans. A restudy of islet hyalin in diabetic and non-diabetic individuals. , 1961, The American journal of pathology.

[57]  E. T. Bell.  Hyalinization of the islets of Langerhans in nondiabetic individuals. , 1959, The American journal of pathology.